GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » EV-to-Revenue

Yili Chuannig Biotechnology Co (SZSE:301301) EV-to-Revenue : 4.48 (As of Sep. 23, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Yili Chuannig Biotechnology Co's enterprise value is ¥25,082 Mil. Yili Chuannig Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ¥5,602 Mil. Therefore, Yili Chuannig Biotechnology Co's EV-to-Revenue for today is 4.48.

The historical rank and industry rank for Yili Chuannig Biotechnology Co's EV-to-Revenue or its related term are showing as below:

SZSE:301301' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.96   Med: 4.95   Max: 7.54
Current: 4.48

During the past 6 years, the highest EV-to-Revenue of Yili Chuannig Biotechnology Co was 7.54. The lowest was 3.96. And the median was 4.95.

SZSE:301301's EV-to-Revenue is ranked better than
64.49% of 1042 companies
in the Biotechnology industry
Industry Median: 7.755 vs SZSE:301301: 4.48

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-23), Yili Chuannig Biotechnology Co's stock price is ¥10.58. Yili Chuannig Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ¥2.46. Therefore, Yili Chuannig Biotechnology Co's PS Ratio for today is 4.30.


Yili Chuannig Biotechnology Co EV-to-Revenue Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co EV-to-Revenue Chart

Yili Chuannig Biotechnology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - - 5.64 4.12

Yili Chuannig Biotechnology Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 4.77 4.12 4.24 5.31

Competitive Comparison of Yili Chuannig Biotechnology Co's EV-to-Revenue

For the Biotechnology subindustry, Yili Chuannig Biotechnology Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yili Chuannig Biotechnology Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yili Chuannig Biotechnology Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Yili Chuannig Biotechnology Co's EV-to-Revenue falls into.



Yili Chuannig Biotechnology Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Yili Chuannig Biotechnology Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=25081.795/5601.563
=4.48

Yili Chuannig Biotechnology Co's current Enterprise Value is ¥25,082 Mil.
Yili Chuannig Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥5,602 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yili Chuannig Biotechnology Co  (SZSE:301301) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Yili Chuannig Biotechnology Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=10.58/2.46
=4.30

Yili Chuannig Biotechnology Co's share price for today is ¥10.58.
Yili Chuannig Biotechnology Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.46.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yili Chuannig Biotechnology Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Yili Chuannig Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000
Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co Headlines

No Headlines